Comprehensive analyses of PBRM1 in multiple cancer types and its association with clinical response to immunotherapy and immune infiltrates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comprehensive analyses of PBRM1 in multiple cancer types and its association with clinical response to immunotherapy and immune infiltrates

Published:2021-03 Issue:6 Volume:9 Page:465-465
ISSN:2305-5839
Container-title:Annals of Translational Medicine
language:
Short-container-title:Ann Transl Med

Author:

Yang Qiuan,Shen Rong,Xu Hanlin,Shi Xiaoliang,Xu Lili,Zhang Lin,Fan Xinglong,Jin Xiangfeng

Publisher

AME Publishing Company

Subject

General Medicine

Link

https://atm.amegroups.com/article/download/65198/pdf

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation;Signal Transduction and Targeted Therapy;2024-09-02

2. Targeted Therapy with Polymeric Nanoparticles in PBRM1-Mutant Biliary Tract Cancers: Harnessing DNA Damage Repair Mechanisms;Critical Reviews in Oncology/Hematology;2024-09

3. Tumor Mutational Load: A Novel Predictor for Clinical Benefit of Pembrolizumab;Clinical Cancer Research;2024-07-08

4. Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery Protocol;Clinical Cancer Research;2024-04-17

5. TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy;Briefings in Bioinformatics;2024-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP